Reimagining Pharma Outsourcing, Beyond Efficiency: Building Ethical, Inclusive, And Patient-Centered Pharma Strategies

  • Reframing pharma outsourcing as a driver of equity, not just efficiency
  • Integrating Traditional and Integrative Medicine (TIM) into global R&D strategies
  • Elevating underrepresented knowledge systems and practitioners through inclusive partnerships
  • Promoting Diversity Equity Inclusion and Belonging (DEIB) values across sourcing, collaboration, and innovation cycles
  • Demonstrating how patient-centered, culturally grounded approaches enhance relevance and resilience in pharma ecosystems